Osteoporosis Medications for Elderly Parents: A Caregiver's Guide to Bone-Strengthening Drugs

Osteoporosis is sometimes called a "silent disease" because bone loss happens without symptoms — until a fracture occurs. For elderly women in particular, a hip fracture caused by osteoporosis can be life-altering. It is the most common cause of loss of independence and nursing home placement in women over 75.

When your parent's doctor prescribes an osteoporosis medication — whether it is a weekly pill, a monthly injection, or an annual infusion — the range of options can feel overwhelming. Evenity, Prolia, Fosamax, Reclast, Boniva — these names sound similar, work very differently, and carry risks that caregivers need to understand before the first dose.

This guide explains the main categories of osteoporosis medications, who they are typically prescribed for, what side effects to watch for, and how to manage them safely at home.

Why Osteoporosis Treatment Matters More in Elderly Patients

Bone density naturally decreases with age. In postmenopausal women, the loss accelerates dramatically due to the decline in estrogen, which plays a key role in maintaining bone mass. By age 70, many women have lost 30–40% of their peak bone mass.

The clinical benchmark is the DEXA scan (dual-energy X-ray absorptiometry), which measures bone mineral density. The result is expressed as a T-score:

• T-score above -1.0: Normal
• T-score between -1.0 and -2.5: Osteopenia (low bone mass, not yet osteoporosis)
• T-score below -2.5: Osteoporosis

A T-score below -2.5 combined with a prior fracture, or a FRAX score (a fracture risk assessment tool) showing high 10-year fracture risk, typically triggers medication treatment.

The goal of treatment is not to grow entirely new bone — it is to slow the breakdown of existing bone and, in some newer medications, to stimulate modest new bone formation. This meaningfully reduces fracture risk, which is the outcome that matters for quality of life.

The Main Categories of Osteoporosis Medications

Bisphosphonates: The First-Line Standard

Bisphosphonates are the most widely prescribed class of osteoporosis drugs. They work by slowing the activity of osteoclasts — the cells that break down bone — allowing bone-building cells to catch up.

Common bisphosphonates prescribed to elderly patients:

Why the annual infusion is often better for elderly patients: The weekly pill (Fosamax) requires a strict administration protocol — taken first thing in the morning, on an empty stomach, with a full glass of water, and the patient must remain upright for 30–60 minutes afterward. For an elderly parent with mobility issues, cognitive decline, or who simply forgets the protocol, this is a high-adherence burden. The annual zoledronic acid infusion (Reclast) eliminates the daily compliance problem entirely — one clinic visit per year, and the medication is handled.

Side effects to monitor:

• GI irritation: The weekly pill form can cause esophageal irritation, heartburn, or stomach pain if not taken exactly as directed. If your parent complains of chest pain or difficulty swallowing after starting a bisphosphonate pill, stop it and call the doctor.
• Flu-like symptoms after infusion: Reclast (and less commonly other bisphosphonates) can cause a 24–72 hour reaction after the first infusion — fever, muscle aches, and fatigue. This is called an "acute phase reaction" and typically resolves on its own. Pre-medicating with acetaminophen and staying well-hydrated helps.
• Jaw problems (rare): Osteonecrosis of the jaw (ONJ) is a rare but serious side effect, most commonly seen in patients on high-dose IV bisphosphonates for cancer treatment. The risk is much lower with standard osteoporosis doses. Dentists should be informed before any invasive dental work if a patient is on bisphosphonates.
• Atypical femur fractures (very rare): With prolonged use (7+ years), there is a small increased risk of unusual fractures in the mid-shaft of the femur. This is rare and must be weighed against the much larger benefit of preventing hip and vertebral fractures.

Drug holidays: After 3–5 years of bisphosphonate treatment, many doctors will recommend a "drug holiday" — a pause of 1–3 years — because the medication's effects persist in the bone even after stopping. Ask the doctor whether a holiday is appropriate, especially if your parent has been on bisphosphonates for many years.

Prolia (Denosumab): The Injection Every Six Months

Prolia works differently from bisphosphonates. It is a biologic medication — a monoclonal antibody — that targets a protein called RANK Ligand (RANKL), which activates the bone-breakdown cells. By blocking RANKL, Prolia essentially turns off the bone-resorption signal.

It is given as a subcutaneous injection (under the skin) every six months, typically by a doctor or nurse in a clinical setting.

Why Prolia is often prescribed to elderly patients:

• No GI side effects (it is not a pill)
• No complex administration protocol
• Works independently of kidney function (important, since many elderly patients have reduced kidney function that limits bisphosphonate use)

The critical warning caregivers must know about Prolia:

You cannot simply stop Prolia. This is not like stopping a weekly vitamin. Prolia's bone-protective effect is not "stored" in the bone the way bisphosphonates are. When Prolia is discontinued — for any reason — bone density drops rapidly, and the risk of vertebral fractures increases significantly (called "rebound bone loss"). This rebound typically occurs within 12–18 months of the last injection.

If your parent needs to stop Prolia for any reason (insurance change, moving to a new provider, hospitalization), a transition medication must be started immediately. This transition is typically a bisphosphonate. Make sure the prescribing doctor has an explicit discontinuation plan in place.

Other Prolia side effects:

• Hypocalcemia (low calcium) — Prolia can lower blood calcium, especially in patients not supplementing adequately. Calcium and Vitamin D supplementation is typically required alongside Prolia.
• Skin infections (cellulitis) — Report any unusual skin redness, swelling, or warmth.
• Joint and muscle pain

Evenity (Romosozumab): The "Build and Protect" Injection

Evenity is the newest and most potent class of osteoporosis medication. It works by a dual mechanism: it simultaneously stimulates bone formation and reduces bone breakdown. No other osteoporosis medication does both at once.

It is given as two subcutaneous injections once a month for 12 months, then stopped. Treatment is limited to one year, after which patients typically transition to a bisphosphonate or Prolia to maintain the gains.

Who Evenity is typically prescribed for:

• Postmenopausal women with severe osteoporosis and very high fracture risk
• Patients who have already fractured on other therapies
• Patients with very low T-scores where bisphosphonates alone are considered insufficient

The cardiovascular warning — this is critical:

Evenity carries an FDA black box warning. Clinical trials found a higher rate of serious cardiovascular events (heart attack, stroke) in patients treated with Evenity compared to those treated with alendronate.

Evenity should not be used in patients who have had a heart attack or stroke in the previous year. Before your parent starts Evenity, confirm with the prescribing physician that the cardiovascular risk has been explicitly evaluated against the fracture risk.

If your parent had a recent cardiac event, ask specifically: "Is Evenity appropriate given her cardiac history, or should we consider a different agent?"

Side effects:

• Injection site reactions (redness, pain at injection site)
• Joint pain, muscle pain
• Headache
• Cardiovascular events (in high-risk patients — see above)

Raloxifene (Evista): The SERM Option

Raloxifene is a Selective Estrogen Receptor Modulator (SERM). It mimics estrogen's bone-protective effects without stimulating breast or uterine tissue — making it an option for women who cannot take estrogen therapy.

It is taken as a daily pill. It modestly reduces vertebral (spine) fracture risk, but it does not reduce hip fracture risk as effectively as bisphosphonates.

Side effects to watch:

• Hot flashes — common in the first months of use
• Deep vein thrombosis (DVT) and pulmonary embolism — Raloxifene increases the risk of blood clots. It should not be used in women with a history of clotting disorders or prolonged immobility.
• Leg cramps

Because of the clot risk and more modest fracture protection, Raloxifene is less commonly used in the very elderly.

Calcium and Vitamin D: The Foundation Underneath the Medication

Every osteoporosis medication is built on top of adequate calcium and Vitamin D. Without these two nutrients, bone-strengthening drugs cannot work effectively.

Current recommendations for elderly adults (65+):

• Calcium: 1,200 mg per day total (from food + supplements). Split supplements into doses of 500–600 mg to maximize absorption.
• Vitamin D: 800–2,000 IU per day. Many elderly adults are significantly deficient, especially those with limited sun exposure.

Important nuance: Calcium supplements carry their own risks. High-dose calcium supplements (1,000+ mg/day from supplements alone) have been associated with increased cardiovascular risk in some studies, and they can cause kidney stones. The goal is to get as much calcium as possible from food (dairy, leafy greens, fortified foods) and use supplements only to make up the gap.

Ask the doctor to check a Vitamin D blood level (25-hydroxyvitamin D) before starting supplementation so the dose can be calibrated to your parent's actual deficiency rather than guessing.

Coordinating Osteoporosis Medication With the Rest of the Medication List

Osteoporosis drugs interact with other commonly prescribed elderly medications in ways caregivers must know:

Bisphosphonates + Antacids or Calcium: Calcium binds to bisphosphonate pills in the stomach, blocking absorption entirely. Bisphosphonate pills must be taken on an empty stomach, separated by at least 30–60 minutes from any other medications, food, or supplements.

Prolia + Corticosteroids: Long-term steroid use (prednisone, dexamethasone) is one of the most common causes of secondary osteoporosis. If your parent is on a steroid for COPD, rheumatoid arthritis, or another condition, discuss whether additional bone protection is needed.

Any Osteoporosis Drug + Falls Risk Medications: The most effective osteoporosis medication in the world cannot prevent a fracture caused by a fall from gabapentin-induced dizziness, a blood pressure med causing orthostatic hypotension, or a benzodiazepine causing sedation. Review all fall-risk medications alongside osteoporosis treatment.

Questions to Ask the Doctor

Before your parent starts any osteoporosis medication:

1. "What is the specific fracture risk we are treating — spine, hip, or both?" Different medications protect different fracture sites. Make sure the chosen drug matches the risk profile.

2. "Given her kidney function, is this medication appropriate at standard doses?" Bisphosphonates require dose adjustment or avoidance in significant kidney disease.

3. "What calcium and Vitamin D supplementation do you recommend alongside this?"

4. "What's the plan if she needs to stop this medication — is there a transition protocol?" Especially critical for Prolia.

5. "Has her cardiovascular history been reviewed against the choice of medication?" Essential if Evenity is being considered.

6. "How will we know if it is working?" Typically a follow-up DEXA scan at 1–2 years.

Tracking Osteoporosis Medications at Home

Osteoporosis medications are easy to mismanage at home — weekly pills get missed, six-month injection appointments are forgotten, annual infusion schedules drift. The consequences of gaps in therapy are real: bone density that took a year to build can be lost quickly if treatment lapses.

A complete medication tracking system helps you stay on top of dosing schedules, flag injection appointment dates, and keep all prescribers informed. Our Medication Management Kit includes a Medication Schedule template, a specialist appointment tracker, and a refill and injection appointment log designed for caregivers managing complex medication regimens for elderly parents.

Get the Medication Management Kit

Osteoporosis treatment is a long-term commitment — typically years, not months. But it is one of the highest-impact interventions available to prevent the fractures that most commonly steal independence from elderly parents. The time spent understanding the medication and monitoring it carefully is time that protects them.